ML-348 – 5 mg

Brand:
Cayman
CAS:
899713-86-1
Storage:
-20
UN-No:
Non-Hazardous - /

Lysophospholipase 1 (LYPLA1) is a protein palmitoyl thioesterase responsible for depalmitoylation of the oncogene HRas.{17771,28661} Palmitoylation of such oncogenes is thought to be required for trafficking and malignant transformation, making LYPLA1 a target for downregulating oncogenic signaling.{17771,28661} ML-348 is a reversible LYPLA1 inhibitor with an IC50 value of 210 nM.{29760} It is 14-fold selective for LYPLA1 over LYPLA2 (IC50 = >3,000) and demonstrates little activity against a panel of more than 20 other serine hydrolases (IC50s = >10,000).{29760}  

 

Available on backorder

SKU: - Category:

Description

A selective, reversible LYPLA1 inhibitor (IC50 = 210 nM)


Formal name: N-[2-chloro-5-(trifluoromethyl)phenyl]-4-(2-furanylcarbonyl)-1-piperazineacetamide

Synonyms:  CID 3238952|SID 160654487

Molecular weight: 415.8

CAS: 899713-86-1

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Phospholipases||Research Area|Lipid Biochemistry|Protein Lipidation